Download Arrhythmogenic Right Ventricular Cardiomypathy (ARVC)

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cardiovascular disease wikipedia , lookup

Quantium Medical Cardiac Output wikipedia , lookup

Saturated fat and cardiovascular disease wikipedia , lookup

Cardiac contractility modulation wikipedia , lookup

Hypertrophic cardiomyopathy wikipedia , lookup

Heart failure wikipedia , lookup

Electrocardiography wikipedia , lookup

Rheumatic fever wikipedia , lookup

Coronary artery disease wikipedia , lookup

Congenital heart defect wikipedia , lookup

Heart arrhythmia wikipedia , lookup

Arrhythmogenic right ventricular dysplasia wikipedia , lookup

Transcript
Arrhythmogenic Right Ventricular
Cardiomypathy (ARVC)
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a condition of the heart muscle
in which normal heart muscle cells on the right-hand side of the heart are replaced by fat
and scar tissue. ARVC is caused by an alteration in a gene that you were born with; it is
not caused by anything you have done or not done (e.g. eaten certain foods, used a
particular product etc). The changes in the heart muscle can cause two main problems.
First, it can affect the electrical system of the heart leading to heart rhythm abnormalities.
Second, the right side of the heart can become enlarged and not pump as it should,
leading to heart failure. Some people with the condition will have no symptoms, others will
develop palpitations, chest pain, dizziness and fainting episodes, and sometimes it can
lead to heart failure or sudden cardiac death, especially in young athletes.
Normal Heart
Arrhythmogenic Right Ventricular
Cardiomyopathy
Right Ventricle
Fatty replacement of
heart muscle
Picture modified from www.heartfoundation.com.au
How it is inherited
ARVC is inherited as an autosomal dominant condition, which means that only one copy of
a gene alteration is required to cause disease (see section on Genetic Inheritance for more
information).
Genetic testing
Major advances have been made in genetic testing for ARVC in recent years. Genetic
testing is now commercially available and involves screening five genes that can cause the
condition. The gene alteration will be identified in approximately 40-50% of families.
Further research is needed to identify more genes involved in this disease.
Treatment
No specific treatments are available but there is evidence that the disease is made worse
by vigorous sporting activity, particularly competitive cycling, so this should be avoided. It is
recommended that people with ARVC see their Cardiologist at least once a year.
Those at highest risk benefit from a pacemaker-defibrillator (ICD- Implantable cardioverter
defibrillator). For more information see the ICD information sheet.
Heart@Heart- version 28/11/2012
This information is a guide and does not replace the advice of your doctor
For more information
To find out more about genetic heart conditions and the latest research news, please visit
the Australian Genetic Heart Disease Registry at www.heartregistry.org.au or the Cardiac
Inherited Diseases Group (New Zealand) at www.cidg.org
Heart@Heart- version 28/11/2012
This information is a guide and does not replace the advice of your doctor